Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 7,500 shares at $34.97 ($269K) on 2014-12-01, disclosed to the SEC on 2014-12-02.
Scheduled sale ($269k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.89 | 1,200 | $42K | 15.6% |
| 2 | $34.97 | 2,600 | $91K | 33.8% |
| 3 | $36.16 | 600 | $22K | 8.1% |
| 4 | $36.24 | 1,100 | $40K | 14.8% |
| 5 | $37.27 | 1,300 | $48K | 18.0% |
| 6 | $37.41 | 700 |
| $26K |
| 9.7% |
| Total | $35.87 avg | 7,500 | $269K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |